Pacira BioSciences Reports First Quarter 2022 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Pacira BioSciences Reports First Quarter 2022 Financial Results

Pacira Pharma (PCRX) Misses Q1 EPS by 19c

May 4, 2022 8:07 AM EDT

Pacira Pharma (NASDAQ: PCRX) reported Q1 EPS of $0.64, $0.19 worse than the analyst estimate of $0.83. Revenue for the quarter came in at $158 million versus the consensus estimate of $159.34 million.

Financial Guidance:

The companys product sales continue to be impacted by COVID-19, which has caused... More